XTLB: XTL Biopharmaceuticals O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
XTL Biopharmaceuticals (XTLB) uchun xavflar moliyaviy beqarorlik va tizimli qizil toshli (lupus) dori vositalarini ishlab chiqishning potentsial muvaffaqiyatsizligi bilan bog'liq. GURU.Markets vaqt grafikidagi P/E o'sish nisbati joriy bozor bahosini tasdiqlaydi, bunda 0.00 yakuniy daraja belgisi vazifasini o'taydi. Biznes himoyasi patentlar va FDA tasdiqlashlariga asoslangan, dori formulalarini kashf qilish samaradorligi esa bioinformatik IT platformalarining avtomatlashtirilishi orqali ta'minlanadi.
XTL Biopharmaceuticals (XTLB) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati XTL Biopharmaceuticals|XTLB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi xtlbio.com|XTLB - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar XTL Biopharmaceuticals, Ltd.|XTLB - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzdorligi XTL Biopharmaceuticals|Oraliq likvidlik koeffitsiyenti xtlbio.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
XTLB - Kompaniyaning sof foydasi|Kutilayotgan foyda XTL Biopharmaceuticals|XTLB - Narx-foyda koeffitsiyenti|Kelajakdagi narx-foyda multiplikatori XTL Bio|XTLB - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati XTL Biopharmaceuticals, Ltd.|XTLB - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda XTL Biopharmaceuticals|XTLB - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi xtlbio.com|XTLB - Joriy yilda bir aksiya uchun foyda o'sishi|Kelgusi yil uchun bir aksiya uchun sof foydaning o'zgarishi prognozi XTL Biopharmaceuticals
Kompaniyaning umumiy tahlili:XTLB - XTL Biopharmaceuticals Ltd
XTL Biopharmaceuticals (XTLB) kapital xarajatlarini minimallashtiruvchi moslashuvchan autsorsing modelidan foydalanadi, bu tendentsiya PEG koeffitsiyentiga asoslangan adolatli qiymatni baholash dinamikasida aks etgan. Ushbu ko'rsatkich joriy P/E multiplikatorini foyda o'sish sur'atlari bilan solishtiradi. Bir birlikdan past qiymat aktivning kengayishiga nisbatan qadrsizlanganligini anglatadi. Ushbu metrika investorlarga o'sishning real xarajatlarini baholash orqali spekulyativ shovqinlarni filtrlash imkonini beradi. Investorlar uchun ushbu signalni klinik sinovlar bilan bog'liq xatarlar bilan bog'lash juda muhimdir.
XTL Biopharmaceuticals kimlar bilan raqobatlashadi
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|DNTH: Narx-foyda va o‘sish multiplikatori|PHVS (Pharvaris Pharma) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|ABCL (abcellera.com) - Narx-foyda va o‘sish multiplikatori|TRML: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Precigen|Narxning foydaga va o‘sish sur’atiga nisbati PHAR|Narx-foyda va o‘sish multiplikatori NKTR (Nektar)|UPB (Upstream Pharma) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ZBIO (Zenas Biopharma Inc)|immunome.com - Narxning foydaga va o‘sish sur’atiga nisbati|Gossamer Bio - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati KalVista Pharma KALV|Septerna Corp (SEPN) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Pieris Corp (PVLA)|Narxning foydaga va o‘sish sur’atiga nisbati Savara Inc.|rigel.com - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori ANAB|ATXS (Astria Therapeutics Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ENGN (enGene Bio)|PEG multiplikatori rapt.com RAPT|JBIO - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACRS (aclaristx.com)|Kyverna Therapeutics, Inc. (KYTX) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Tiziana Life Sciences Ltd.|CABA (Cabaletta Bio, Inc) - PEG multiplikatori|PEG multiplikatori Ventyx Biosciences, Inc|PEG multiplikatori THTX|Narx-foyda va o‘sish multiplikatori avalotx.com AVTX|PEG multiplikatori ELDN (Eledon Pharmaceuticals, Inc.)|Agenus, Inc. (AGEN) - O‘sish sur’atiga tuzatilgan narx-foyda|CLYM: Narx-foyda va o‘sish multiplikatori|ZURA - PEG multiplikatori|ATYR (aTyr Pharma, Inc.) - Narx-foyda va o‘sish multiplikatori|ADAG: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|IMA (ImageneBio) - PEG multiplikatori|Shattuck Therapeutics (STTK) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori EQ|Narx-foyda va o‘sish multiplikatori connectbiopharm.com CNTB|PEG multiplikatori IMUX (Immunic)|PEG multiplikatori Atara Biotherapeutics, Inc. ATRA|IFRX - Narxning foydaga va o‘sish sur’atiga nisbati|XFOR: Narxning foydaga va o‘sish sur’atiga nisbati|adicetbio.com (ACET) - Narxning foydaga va o‘sish sur’atiga nisbati|CELU - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori INMB|O‘sishni hisobga olgan narx-foyda koeffitsiyenti BRNS (barinthusbio.com)|Narx-foyda va o‘sish multiplikatori KZR (Kezar Life Sciences, Inc.)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati SABS|Narxning foydaga va o‘sish sur’atiga nisbati Akari Therapeutics plc AKTX|Enlivex Therapeutics Ltd - Narxning foydaga va o‘sish sur’atiga nisbati|Q32 Bio Corp - PEG multiplikatori|GOVX: Narxning foydaga va o‘sish sur’atiga nisbati|Edesa Biotech (EDSA) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati IBIO (iBio Inc)|CARM (Carisma Therapeutics Inc) - PEG multiplikatori|BOLT: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori HCWB|PEG multiplikatori aptevotherapeutics.com (APVO)|Narxning foydaga va o‘sish sur’atiga nisbati AIM ImmunoTech AIM|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ADTX|GRI - Narxning foydaga va o‘sish sur’atiga nisbati|XORTX Corp (XRTX) - Narx-foyda va o‘sish multiplikatori|HIND: PEG multiplikatori|revbiosciences.com (REVB) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori INDP|SCNI: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori CALI|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati affimed.com|Narxning foydaga va o‘sish sur’atiga nisbati Allakos ALLK|HOOK - Narx-foyda va o‘sish multiplikatori|IGMS - Narxning foydaga va o‘sish sur’atiga nisbati|iTeos Therapeutics Inc (ITOS) - Narx-foyda va o‘sish multiplikatori|OCEA (Ocean Bio) - Narx-foyda va o‘sish multiplikatori|TC BioPharm Ltd (TCBP) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Third Harmonic Bio
